SFB — Sopharma Buildings ADSITS Income Statement
0.000.00%
Last trade - 00:00- BGN58.50m
- BGN65.69m
- BGN0.09m
Annual income statement for Sopharma Buildings ADSITS, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.149 | 0.079 | 0.257 | 0.062 | 0.085 |
| Cost of Revenue | |||||
| Gross Profit | 0.125 | 0.053 | 0.229 | -0.637 | -6.04 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.073 | 0.074 | 0.078 | 0.206 | 0.177 |
| Operating Profit | 0.076 | 0.005 | 0.179 | -0.144 | -0.092 |
| Net Income Before Taxes | 0.076 | 0.005 | 0.179 | -0.144 | -0.092 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.076 | 0.005 | 0.179 | -0.144 | -0.092 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.076 | 0.005 | 0.179 | -0.144 | -0.092 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.076 | 0.005 | 0.179 | -0.144 | -0.092 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.019 | 0.001 | 0.045 | -0.037 | -0.024 |
| Dividends per Share |